{
  "resourceType": "MedicinalProductDefinition",
  "id": "EMLA-2525-Plaster-SE-AJ-MedicinalProductDefinition",
  "meta": {
    "profile": [
      "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
    ]
  },
  "identifier": [
    {
      "system": "http://ema.europa.eu/fhir/mpId",
      "value": "SE-100001718-00011834"
    },
    {
      "system": "http://ema.europa.eu/fhir/eurdId",
      "value": "1867"
    }
  ],
  "combinedPharmaceuticalDoseForm": {
    "coding": [
      {
        "code": "100000073714",
        "system": "https://spor.ema.europa.eu/v1/lists/200000000004",
        "display": "Medicated plaster"
      }
    ]
  },
  "domain": {
    "coding": [
      {
        "code": "100000000012",
        "system": "https://spor.ema.europa.eu/v1/lists/100000000004",
        "display": "Human use"
      }
    ]
  },
  "status": {
    "coding": [
      {
        "code": "200000005004",
        "system": "https://spor.ema.europa.eu/v1/lists/200000005003",
        "display": "Current"
      }
    ]
  },
  "indication": "Emla plåster används vid: • Ytanestesi av intakt hud i samband med: o nålstick, t.ex. vid inläggning av perifer venkateter eller vid blodprovstagning o ytliga kirurgiska ingrepp, hos vuxna och den pediatriska populationen",
  "legalStatusOfSupply": {
    "coding": [
      {
        "code": "200000002239",
        "system": "https://spor.ema.europa.eu/v1/lists/100000072051",
        "display": "Medicinal product subject to medical prescription exempt for some pack sizes"
      }
    ]
  },
  "classification": [
    {
      "coding": [
        {
          "code": "100000097205",
          "system": "https://spor.ema.europa.eu/v1/lists/100000093533",
          "display": "N01BB20"
        }
      ]
    }
  ],
  "name": [
    {
      "productName": "EMLA 25 mg/25 mg Medicinskt plåster"
    }
  ]
}
